Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.4690 +0.0090 (+1.96%) Official Closing Price Updated: 8:00 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 195,480 Open 0.4839 Bid (Size) 0.4620 (2) Ask (Size) 0.4833 (8) Prev. Close 0.4600 Today's Range 0.4610 - 0.4900 52wk Range 0.2501 - 0.9099 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives ‘Buy’ Recommendation in AGP’s Analyst Coverage Research Report July 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target July 18, 2024 From IGC Pharma, Inc. Via Business Wire Performance YTD +69.93% +69.93% 1 Month -0.09% -0.09% 3 Month +5.37% +5.37% 6 Month +75.33% +75.33% 1 Year +42.12% +42.12% More News Read More BioMedNewsBreaks — IGC Pharma Inc.’s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings July 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile July 09, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Positive Data from TGR-63 Preclinical Studies June 26, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Financial Report for Fiscal Year June 25, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease June 25, 2024 From IGC Pharma, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Via InvestorPlace IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024 June 24, 2024 Via InvestorPlace IGC Reports Financial Results for Fiscal Year Ended March 31, 2024 June 24, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event June 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets June 18, 2024 From IGC Pharma, Inc. Via Business Wire Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected June 13, 2024 Via Benzinga Topics Cannabis Regulatory Compliance Exposures Cannabis Legal Regulatory 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal June 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol June 10, 2024 From IGC Pharma, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 31, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 From IGC Pharma Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024 May 22, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Attend BIO International Convention 2024 May 21, 2024 From IGC Pharma Inc. Via Business Wire 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings May 09, 2024 Via News Direct 6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings May 09, 2024 Via TheNewswire.com Topics Cannabis Exposures Cannabis Product Safety 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
